(-)-chicoric acid,
(-)-L-chicoric acid,
2,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)butanedioic acid,
chicoric acid,
cichoric acid,
dicaffeoyltartaric acid,
L-chicoric acid,
Chicoric acid,
Cichoric Acid,
L-Chicoric acid,
70831-56-0,
6537-80-0,
UNII-S4YY3V8YHD,
L-Cichoric acid,
NSC 699173,
(2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid,
NSC699173,
S4YY3V8YHD,
dicaffeoyltartaric acid,
2,3-Bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)butanedioic acid,
CHEBI:3594,
CHEMBL282731,
(-)-Chicoric acid,
(R-(R*,R*-(E,E)))-2,3-Bis((3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)butanedioic acid,
(2R,3R)-2,3-bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)succinic acid,
(2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid,
Butanedioic acid, 2,3-bis(((2E)-3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)-, (2R,3R)-,
Butanedioic acid, 2,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, (2R,3R)-,
L-DCTA,
Butanedioic acid, 2,3-bis((3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)-, (R-(R*,R*-(E,E)))-,
Dicaffeoyl-L-tartaric acid,
(-)-L-Chicoric acid,
1-chicoricacid,
Cichoric-Acid,
l-Chicoric-acid,
(2R,3R)-2,3-Bis[[(E)-3-(3,4-dihydroxyphenyl)acryloyl]oxy]succinic Acid,
C22H18O12,
( -)-Chicoric acid,
( ?)-Chicoric acid,
ECH PURPUREA PE,
Chicoric acid, (-)-,
Echinacea Purpurea powder,
L-CA,
ECH ANGUSTIFOLIA PE,
AC1NQZ18,
AC1Q5R3N,
DSSTox_CID_13332,
DSSTox_RID_79064,
DSSTox_GSID_33332,
Echinacea Purpurea Root Extract,
DTXSID0033332,
SCHEMBL15532218,
2,3-Dicaffeoyl-L-tartaric acid,
HY-N0457A,
YDDGKXBLOXEEMN-IABMMNSOSA-N,
2,3-Di-trans-caffeoyltartaric acid,
Chicoric Acid, >=95% (HPLC),
HY-N0457,
ZINC4098726,
Tox21_201055,
BDBM50076273,
MFCD00189418,
AKOS000278435,
CS-4262,
CS-4263,
MCULE-6145113836,
NSC-699173,
( -)-Chicoric acid, analytical standard,
NCGC00091914-01,
NCGC00091914-02,
NCGC00258608-01,
AN-37657,
CAS-70831-56-0,
LS-176843,
TR-037560,
C3450,
C10437,
831C560,
Chicoric Acid, United States Pharmacopeia (USP) Reference Standard,
(2R,3R)-2,3-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)succinic acid,
(2r,3r)-2,3-bis{[3-(3,4-dihydroxyphenyl)acryloyl]oxy}butanedioic acid,
(2R,3R)-2,3-Bis-[(E)-3-(3,4-dihydroxy-phenyl)-acryloyloxy]-succinic acid,
(2R,3R)-2,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy}butanedioic acid,
(2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}succinic acid,
(2R,3R)-2,3-bis{[3-(3,4-Dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid,
[S-(R*,R*)]-2,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]butanedioic acid,
Butanedioic acid, 2,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (R-(R*,R*))-,
Butanedioic acid, 2,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, (2R,3R)- (9CI),
Butanedioic acid, 2,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, [R-[R*,R*-(E,E)]]-,
GKP,
NCGC00091914-04!(2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid,
CichoricAcid,
no translation,
PENTAERYTHRITOL,
HIV-1 Integrase Inhibitor,
ACN-035469,
CID5281764,
C22-H18-O12,
C100435,
Chicoric acid, 98%, from Echinacea purpurea - 20MG 20mg,
Chicoric acid, 98%, from Echinacea purpurea (L.) Moench - 25MG 25mg,
(2r,3r)-2,3-bis[[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioicacid,
butanedioic acid, 2,3-bis(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-, (2R,3R)-,
Draw
SDS
COA
Add to Cart
